Mersana Therapeutics, Inc.: capex
| Value | {"amount": 372000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-03-31 |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/da236f13-6dd1-4e09-9f35-86e3c150a6c1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-19-004673Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/capex/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/da236f13-6dd1-4e09-9f35-86e3c150a6c1
History
- no predecessors — first report